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Recent anatomic studies in our laboratory identified the nucleus prepositus hypoglossi (PrH) in the dorsomedial medulla as a major afferent of the locus coeruleus (LC). In the present studies, the influence of projections from PrH to LC was assessed in anesthetized rats. Focal electrical stimulation of PrH inhibited the spontaneous discharge of 42 of 47 LC neurons; the latency to onset of such inhibition was 19.8 + 2.5 msec and its duration was 172.4 +-10.4 msec. PrH-evoked inhibition of LC neurons was unaffected by administration of the opiate receptor antagonist naloxone or the a,-receptor antagonist idazoxan but was substantially reduced by systemic picrotoxin, an antagonist of GABA. The GABA, receptor antagonist bicuculline methiodide blocked the inhibition from PrH, whether applied by local microinfusion or iontophoresis into the LC. These results lead us to propose that PrH provides a direct inhibitory synaptic input to LC, for which GABA is the likely transmitter.
Recent anatomic studies (A&on-Jones et al., 1986; demonstrate that the nucleus locus coeruleus (LC) receives a restricted number of afferent inputs, with the bulk of LC innervation arising from 2 medullary nuclei: nucleus prepositus hypoglossi (PrH), previously reported to innervate LC (Cedarbaum and Aghajanian, 1978b) , in the dorsomedial medulla (Altman and Bayer, 1980) and the nucleus paragigantocellularis in the ventrolateral medulla. The strong input to the LC from these 2 nuclei indicates that they may be the predominant elements controlling the divergent efferent network of this noradrenergic system. In agreement with these anatomical results, recent electrophysiological experiments reveal that nucleus paragigantocellularis exerts a robust, predominantly excitatory influence on LC Aston-Jones, 1986a, 1988) .
The physiologic influence of the other major afferent, PrH, on LC has not been characterized. Immunocytochemical studies reveal that neurons in the PrH area stain for markers of several neurotransmitters reported to innervate LC, including ACh Stimulation electrode implantation. Male Sprague-Dawley rats (275-375 gm) were anesthetized with 400 mg/kg chloral hydrate intraperitoneally. Anesthesia was maintained throughout experiments with additional injections of chloral hydrate as needed. Core temperature was maintained at 36-38°C with a feedback-controlled heating pad. Rats were intubated with a tracheal cannula and placed in a stereotaxic instrument with the snout lowered to place the skull 20" from the horizontal plane. The skin and neck muscles overlying the medulla were excised, and the occipital plate was removed. The dura covering the medulla and caudal cerebellum were removed to expose the caudal apex of the IVth ventricle. A stimulation electrode, consisting of a pair of twisted 125~rm-diameter wires, was implanted in PrH (2.1-2.5 mm rostra1 to obex, 0.1-0.5 mm lateral to midline, 0.1-0.5 mm below the dorsal medullary surface). Extracellular recordings were used to localize the PrH before stimulation electrode implantation as follows. A recording micropipette was centered at the coordinates for PrH (above) and lowered through the cerebellum. The depth of the dorsal medullary surface was noted, and the stimulation electrode was implanted 0.1-0.5 mm below the dorsal medullary surface. In addition, 2 electrodes (26 gauge needles) were placed subcutaneously in the medial footpad contralateral to recording sites for bipolar stimulation of the sciatic nerve (Aston-Jones et al., 1982; Ennis and Aston-Jones, 1986b) . Stimulation electrodes were connected to a Grass S88 stimulator and a constantcurrent stimulus isolation unit (Grass PSIU6). Logic pulses synchronized with brain or footpad stimuli were led to a computer for on-line peristimulus time histogram generation. LC recordings. In the above animals, a hole was drilled in the skull at the coordinates for LC (4.7 mm posterior to lambda, 1.2 mm lateral to midline), and the underlying dura was reflected. A glass micropipette (2-4 pm tip diameter, lo-20 MQ impedance) filled with 2% pontamine sky blue in 0.5 M sodium acetate was stereotaxically positioned in the LC area with a hydraulic microdrive. Extracellular recordings from individual neurons were amplified and displayed as filtered (500 Hz-10 kHz bandpass) and unfiltered electrode signals. Action potentials were isolated from background activity with a waveform discriminator that generated logic pulses for signals that crossed a lower voltage gate, peaked below an upper voltage gate, and passed through a time window at a preset voltage and delay. Logic pulses were led to a computer and a chart recorder for on-line data collection. Impulse activity was also monitored with a loudspeaker.
LC neurons were tentatively identified at the time of recording on the basis of characteristic impulse waveforms and spontaneous and evoked discharge patterns as previously reported (Cedarbaum and Aghajanian, 1978a; Ennis and Aston-Jones, 1988 time histograms, typically generated at 1.5 times the threshold for apparent inhibition, or 20-60 V for footpad stimulation, were accumulated for 50 consecutive stimulus trials at 0.5 Hz. Systemic drug administration. Intravenous (iv) injections were made into a lateral tail vein. Idazoxan (0.1 or 0.5 mg/ml), naloxone hydrochloride (0.5 mg/ml), or picrotoxin (3.0 mg/ml) were prepared in distilled water daily. Local microinfusion. Bicuculline methiodide (30-180 nl of a 17-330 Microiontophoresis. A 7-barrel iontophoretic micropipette (lo-20 Frn tip diameter) was glued to an independent single-barrel recording micropipette (2-4 pm-tip diameter, described above), placing the recording micropipette tip 20-35 pm below the 7-barrel array. The center and one outer barrel of the iontophoretic pipette were filled with 4 M NaCl. The center NaCl barrel was used to neutralize continuously tip potential through an automatic current-balancing circuit, while the outer NaCl barrel was used for control current ejection. The other 5 barrels were filled with desired drug solutions (see below). Iontophoretic solutions were ejected with currents of l-200 nA, and retained with currents of l-10 nA. The following iontophoretic solutions were used: bicuculline methiodide (0.01 M, pH 4), GABA (0.1 M, pH 4) and strychnine hydrochloride (0.0 1 M, pH 5). Continuous iontophoretic application of an antagonist was initiated 1.5 min before, and continued throughout, accumulation of postdrug peristimulus time histograms.
Histology. Micropipette penetrations were marked by iontophoretic ejection of dye with current pulses (-7 FA, 50% duty cycle for 10 min). At the end of recording sessions, +30 PA was passed through the stimulation electrode for 1 min to deposit iron at electrode tips. Animals were then deeply anesthetized and perfused with 10% formaldehyde in 0.1 M phosphate buffer containing 5% potassium ferrocyanide. Brains were removed and stored in a similar solution containing 10% sucrose. Select brain regions were cut into 50-pm-thick frozen sections and stained with Neutral red. All stimulation and recording sites were histologically localized from such tissue sections (Fig. 1) .
Data analysis. Peristimulus time histograms were used to analyze evoked responses from PrH or footpad stimulation. The mean and SD of counts per bin were determined for a baseline period, defined as the 500 msec epoch preceding stimulation. The onset of excitation was defined as the first of 5 consecutive bins (8 msec bin width) whose mean value exceeded mean baseline activity by 2 SD, and response offset was determined as the time at which activity had returned to be consistently Inhibition was defined as an epoch of at least 15 bins in which the mean count per bin was less than 35% of that during baseline. Response magnitude for inhibition was calculated as follows: Inhibition R,,, = (counts in inhibitory epoch)
-(mean counts per baseline bin x number of bins in inhibitory epoch).
Results

Evoked responses
As shown for a typical cell in Figure 2A , single-pulse electrical stimulation (0.5 Hz) of PrH produced short-latency, phasic inhibition of LC discharge. Overall, 42 of 47 LC neurons (89%) were inhibited from PrH stimulation, with a mean onset latency of 19.8 f 2.5 msec and a mean duration of 172.4 f 10.4 msec. Two cells were synaptically activated, and 3 other cells were unaffected from such stimulation.
Pharmacology of evoked responses Picrotoxin. The GABA antagonist picrotoxin, at doses of 3 (n = 3) or 6 (n = 4) mg/kg, iv, significantly attenuated the inhibition of LC from PrH (p < 0.03, paired t test), completely blocking such inhibition in 5/7 cells (Fig. 2) . Picrotoxin at these doses elicited twitching of the face and flank. In contrast to the blockade of inhibition from PrH, picrotoxin had no effect on excitatory responses of LC neurons to footpad stimulation (Fig. 2) nor on the inhibitory period that followed footpad-evoked excitation (n = 4, p > 0.5, for each).
Locally infused bicuculline methiodide. As shown in Figure 3 , microinfusion of 0.5-5.0 ng bicuculline methiodide into the LC completely blocked PrH-evoked inhibition in 1 O/ 11 cells tested (p < 0.02, paired t test). In 3 of these neurons, bicuculline methiodide infusion also disclosed an underlying excitatory response to PrH stimulation not observed in predrug experiments. PrH-evoked inhibition of one LC neuron was not affected after microinfusion of bicuculline methiodide. As illustrated in Figure of 58.6%. Current ejection through an adjacent NaCl electrode did not affect LC discharge. Iontophoretically applied bicuculline methiodide significantly decreased the magnitude of GABAevoked inhibition of LC discharge (mean decrease, 65.3%; II = 5, p < 0.02, Mann-Whitney test), although bicuculline methiodide did not completely reverse this inhibition (Fig. 4) . Continuous iontophoretic application of bicuculline methiodide (20-100 nA) increased the mean spontaneous discharge rate of LC neurons (n = 10) from 2.1 f 0.3 to 3.1 f 0.4 Hz (p < 0.004, paired t test). The increase in spontaneous discharge evoked by bicuculline methiodide was of slow onset, typically developing after 1.5-3 min. Application ofbicuculline methiodide with high currents (> 100 nA) or for prolonged periods often increased the spontaneous discharge rate of LC neurons to 6-10 Hz.
The effect of iontophoretically applied bicuculline methiodide on PrH-evoked inhibition of LC was examined with 22 neurons. Bicuculline methiodide (20-100 nA) completely blocked such inhibition in 19/22 cells tested (Figs. 5, 6 ) and caused a significant overall attenuation of this response (p < 0.01, paired t test). Full or partial recovery of PrH-evoked inhibition was observed 5-12 min after termination of the ejection current. Inhibition of LC discharge from PrH was not altered by ejection of similar currents through an adjacent barrel containing NaCl (n = 6; p > 0.1, paired t test).
In 5 of these neurons, iontophoretic application of bicuculline methiodide converted the inhibitory response to PrH stimulation into an excitation. Such excitation rapidly decayed after termination of bicuculline methiodide, with evoked inhibition returning after 2-10 min.
As shown in Figure 5 , footpad-evoked excitation of LC neurons was not significantly affected by iontophoretically applied bicuculline methiodide (n = 9; p > 0.5, paired t test). In addition, bicuculline methiodide had no overall effect on postactivation inhibition following such excitation (n = 7, p > 0.1, paired t test), although such inhibition was blocked in one cell.
In contrast to bicuculline methiodide, iontophoretic application of the glycine antagonist strychnine hydrochloride (80-100 nA) did not affect the magnitude of PrH-evoked inhibition of LC discharge (n = 6; p > 0.1, paired t test; Fig. 6 ).
Idazoxun. Idazoxan at doses of 0.1 mg/kg (n = 1) or 0.5 mg/ kg (n = 5), iv, did not significantly attenuate the magnitude of PrH-evoked inhibition ( Fig. 7 ; p > 0.1, paired t test), nor did it block such inhibition in any individual neuron. As expected, idazoxan significantly increased the mean spontaneous discharge rate of these neurons from 1.6 -t 0.4 to 2.5 + 0.4 Hz (n = 6, p < 0.005, paired t test).
Nuloxone. As illustrated for a typical cell in Figure 8 , naloxone (0.5 or 1 .O mg/kg, iv) did not attenuate PrH-evoked inhibition of LC discharge (n = 5; p > 0.10, paired t test) and did not alter the spontaneous discharge rate of LC neurons (n = 4; p > 0.4, paired t test).
Di8CU88iOn
The present study has characterized the regulatory influence of the PrH on the activity of LC neurons. Our results indicate that PrH, anatomically identified as 1 of 2 major afferent inputs to LC (Aston-Jones et al., 1986) , exerts a nearly uniformly inhibitory influence on the discharge of LC neurons. In addition, our pharmacologic analysis indicates that PrH-evoked inhibition of LC is mediated by GABA, acting primarily at the GABA, receptor subtype.
Several findings indicate that the inhibition of LC neurons from PrH stimulation is a direct response to input from cells in the PrH area. (1) The latency for synaptic inhibition of LC neurons from PrH (mean onset latency = 19.8 msec) is similar to the latencies for PrH neurons antidromically activated from LC (range of latencies = 1 O-23 msec, mean latency = 16 msec; Ennis and Aston-Jones, 1989) , indicating that the responses observed here result from activation of a slowly conducting fiber pathway from PrH cells. (2) Stimulation of the nucleus tractus solitarius in the dorsal medulla caudal to PrH has no consistent effect on the discharge of LC neurons (Ennis and Aston-Jones, 1989) . Activation of the other major afferent input to LC, nucleus paragigantocellularis in the ventrolateral medulla, yields predominant activation of LC neurons . Structures adjacent to PrH (i.e., medial vestibular nucleus) do not project to LC (Aston-Jones et al., 1986) . (3) No LC neurons were antidromically activated, and only 2 cells were synaptically activated from PrH stimulation, indicating that PrHevoked inhibition is not due to collateral-mediated postactivation inhibition reported for LC neurons (Aghajanian et al., 1977; Cedarbaum and Aghajanian, 1978a; Ennis and AstonJones, 1986b) . Furthermore, the failure of the Lu,-receptor antagonist idazoxan to block PrH-evoked inhibition (see below) provides additional evidence that this inhibition is not mediated by noradrenergic collateral interactions in LC or by epinephrine inputs from the ventrolateral medulla .
The neurochemical identity of projections from PrH to LC have not been fully characterized with double-labeling techniques. However, recent experiments reveal that although PrH neurons retrogradely labeled from LC are located in the area of the C3 adrenergic cell group, there appear to be only minor adrenergic projections from PrH to LC. The present finding that high intravenous doses of the a2-receptor antagonist idazoxan did not alter PrH-evoked inhibition is consistent with these anatomic results indicating no prominent adrenergic input to LC from PrH.
Immunohistochemical studies by others demonstrate the presence of enkephalin-containing cells in PrH (Khachaturian et al., 1983) and enkephalinergic fibers in LC (Pickel et al., 1979) . However, the lack of effect of naloxone in the present experiments, at a dose well above that previously shown to reverse opiate-induced inhibition of LC (Bardo et al., 1983) indicates that PrH-evoked inhibition of LC neurons is probably not mediated by enkephalin.
Some PrH neurons also stain for glutamic acid decarboxylase (Mugnaini and Oertel, 1985) , a synthetic enzyme for GABA, and for GABA itself (Pieribone et al., unpublished observations) . In addition, immunohistochemical studies reveal a rich plexus of glutamic acid decarboxylase-positive fibers and terminals in LC (Berod et al., 1984; Mugnaini and Oertel, 1985; Ijima and Ohtomo, 1988; Shipley et al., 1988) and GABA receptors have also been demonstrated in the LC (Wamsley and Palacios, 1984) . The possibility that GABA may mediate PrHevoked inhibition of LC is consistent with in vivo and in vitro pharmacologic findings here and elsewhere that GABA directly applied inhibits spontaneous discharge of LC neurons (Cedarbaum and Aghajanian, 1976 Aghajanian, , 1977 Guyenet and Aghajanian, 1979; Osmanovic and Shefner 1987, 1988) . However, recent studies also have disclosed GAD-positive neurons in the vicinity of LC (Ijima and Ohtomo, 1988; Shipley et al., 1988) ; these results raise the possibility that some PrH afferents may act through such local GABAergic neurons.
In the present experiments, iontophoretically applied GABA inhibited the spontaneous discharge rate of LC neurons by as much as 80%. Bicuculline methiodide, a selective GABA, receptor antagonist (Lloyd and Morselli, 1987) , attenuated GABAevoked inhibition by 58-70%. GABA-evoked inhibition remaining in the presence of bicuculline may be mediated by the action of GABA on bicuculline-insensitive GABA, receptors, as Osmanovic and Shefner (1988) have reported that GABA simultan;eously inhibits LC neurons via activation of GABA, and GABA, receptor subtypes. Iontophoretically applied bicuculline methiodide increased the spontaneous discharge rate of some LC neurons; in some cases, spontaneous rate was increased above the normal discharge rates of LC neurons in anesthetized rats (0.5-5.0 Hz), indicating that this effect may not be due simply to antagonism of GABA leakage from the iontophoretic pipette, but may reflect tonically active GABAergic input to LC. The ability of intravenous picrotoxin to attenuate or completely block PrH-evoked inhibition of LC neurons indicates that this inhibition is mediated by GABAergic projections from PrH to LC. This finding is tempered by observations that the effects of picrotoxin are not of sufficient specificity to delineate GABA-mediated responses conclusively. However, several other results of the present studies indicate that PrH-evoked inhibition is mediated by GABA. (1) Local infusion or microiontophoretic application of the specific GABA, receptor antagonist bicuculline methiodide blocked PrH-evoked inhibition in the majority of cells tested with this agent, (2) iontophoretic application of the glycine antagonist strychnine did not antagonize PrH-evoked inhibition of LC neurons, and (3) picrotoxin and bicuculline methiodide did not significantly alter excitation or postactivation inhibition of LC cells following footpad stimulation, indicating that these agents did not have nonspecific effects on other synaptically mediated responses of LC neurons.
It should be noted that in some LC neurons bicuculline methiodide revealed an underlying excitatory response to PrH stimulation that was not observed in these cells prior to administration of this agent. The number of cells excited from PrH after bicuculline methiodide administration (8/33) was greater than the number of cells excited in control studies (2/47). These findings indicate that there may be a modest excitatory component in the pathway from PrH to LC in addition to the more prominent GABAergic projections. Thus, in control stimulation * GABAergic Pathway Inhibits Locus Coerul eus PrH Stim. experiments, activation of inhibitory inputs from PrH may predominate and mask the influence of less potent excitatory projections. Such an effect of GABA is consistent with the membrane hyperpolarization and "shunting" actions of this neurotransmitter (Alger, 1985) ; both of these effects would tend to decrease the response to a coactivated excitatory input to the same cell. Additional experiments are necessary to confirm possible excitatory projections from PrH to LC. Our conclusion that PrH-evoked inhibition of LC neurons is mediated by GABA, operating primarily at a GABA, receptor, is in agreement with recent observations in vitro by Cherubini et al. (1988) . Electrical field stimulation of LC slices elicit both excitatory and inhibitory postsynaptic potentials measured intracellularly in LC neurons. Such postsynaptic potentials are not observed in a low-calcium medium (Egan et al., 1983) and are presumably mediated by neurotransmitter released from terminals of afferent fibers contained in the slice. Cherubini et al. have demonstrated that such field stimulation-evoked postsynaptic potentials consist of 2 primary components distinguished on the basis of pharmacologic sensitivity and ionic dependence: (1) a bicuculline-insensitive postsynaptic potential, antagonized by the excitatory amino acid antagonist kynurenic acid, and (2) a kynu;renic acid-insensitive, chloride-dependent postsynaptic potential antagonized by bicuculline. Cherubini et al. conclude that the postsynaptic potential antagonized by bicuculline results from stimulation-evoked release of GABA. In light of the present in vivo findings, it seems probable that this bicucullinesensitive postsynaptic potential is mediated, at least in part, by GABA released from PrH terminals in the LC slice. We have previously reported that activation of paragigantocellularis excites LC neurons, an effect that is blocked by the excitatory amino acid antagonists kynurenic acid or gamma-D-glutamylglycine . The postsynaptic potential observed by Cherubini et al. that was antagonized by kynurenic acid, but not by bicuculline, may be mediated by an excitatory amino acid released from terminals of paragigantocellularis fibers contained in the LC slice.
The function of this major inhibitory input to LC is at present unclear. However, previous experiments recording LC activity in unanesthetized behaving rats 198 1) found that these neurons were largely silent during paradoxical sleep. Examination of field potential activity in LC in this same study indicated that the markedly reduced spontaneous and sensory-evoked discharge during paradoxical sleep was probably the result of tonic inhibition impinging on LC from an extrinsic afferent. It was further proposed that such a tonic inhibitory afferent may be responsible for the decreased activity and sensory responsiveness found for these cells during other nonvigilant behaviors such as slow-wave sleep, grooming, and consumption. The inhibition reported here from PrH could reveal the pathway responsible for such behavioral state-dependent inhibition of LC. The input from PrH is not the only possible source of such inhibition, however. Recent results ) demonstrate a prominent adrenergic input to LC from the nucleus paragigantocellularis in the rostra1 ventrolateral medulla, and previous studies have shown epinephrine to be inhibitory on LC discharge Aghajanian, 1976, 1977) . Thus, this adrenergic pathway from the paragigantocellularis provides another source of inhibitory control over LC in addition to the presently described GABAergic projection from PrH. Experiments are underway to clarify the function of these inhibitory afferents to LC and to determine if these inputs mediate state-dependent inhibition of LC.
In conclusion, our results identify a strong inhibitory synaptic input to LC, emanating from a major afferent to this nucleus, PrH. This inhibition appears to be mediated by GABA, acting at the GABA, receptor subtype on LC neurons.
